ADDLs and the signaling web that leads to Alzheimer's disease

Neuropharmacology
Grant A Krafft, William L Klein

Abstract

Today, it is widely accepted that ADDLs, soluble oligomeric assemblies of the amyloid beta peptide, play a prominent role in triggering the cognitive deficits and neurodegeneration that constitute Alzheimer's disease (AD). Within the past decade, the longstanding emphasis on fibrillar deposits and neuronal death has given way to a new paradigm involving ADDL-triggered aberrant synaptic signaling and consequent memory malfunction and neurodegeneration. As with any paradigm shift in biology, not all molecular details have been elucidated, and not all AD scientists are fully subscribed. Nevertheless, the ADDL paradigm affords a promising framework for ongoing AD research and for development of the first therapeutics endowed with the dual capabilities of immediate symptom reversal and long-term disease modification. In this review we provide a brief account of the discovery of ADDLs, followed by a summary of key results that address questions concerning ADDL structure and assembly, biological activity and therapeutic possibilities.

References

Nov 9, 1992·Neuroscience Letters·V TancrediF Eusebi
Sep 1, 1992·Neurobiology of Aging·J WaiteL J Thal
Apr 10, 1992·Science·J A Hardy, G A Higgins
Apr 1, 1991·Neuron·D J Selkoe
Mar 1, 1989·Neurology·J E HamosD A Drachman
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·A Lorenzo, B A Yankner
Nov 1, 1993·Journal of Neurochemistry·C Vigo-PelfreyD B Schenk
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·B SolomonT Katzav
Feb 23, 1996·The Journal of Biological Chemistry·Y M KuoA E Roher
Aug 1, 1997·Journal of Neuropathology and Experimental Neurology·C I SzeL J Martin
Nov 5, 1997·Journal of Neuropathology and Experimental Neurology·J W ChangJ B Watson
Jun 22, 1999·Journal of Neuropathology and Experimental Neurology·K HatanpääS I Rapoport
Jun 1, 2000·Journal of the Neurological Sciences·C I SzeL J Martin
Mar 1, 1991·History of Psychiatry·A AlzheimerR Levy
Jun 12, 2002·The Journal of Biological Chemistry·Karie N DahlgrenMary Jo LaDu
Apr 2, 2003·Nature Reviews. Drug Discovery·Tim TullyJohn Tallman
Nov 5, 2003·Biochemistry·Brett A ChromyWilliam L Klein
May 19, 2004·The European Journal of Neuroscience·Igor KlyubinMichael J Rowan
Aug 31, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Fernanda G De FeliceSérgio T Ferreira
Dec 4, 2004·The Journal of Clinical Investigation·Bing GongOttavio Arancio
Jul 14, 2005·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Gal BitanDavid B Teplow
Jan 21, 2006·Nature Reviews. Drug Discovery·Stuart A Lipton
Apr 14, 2006·Current Alzheimer Research·John B Standridge
Apr 14, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Catherine CreeleyJohn W Olney
Apr 28, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Angela M Floden, Colin K Combs
Jun 15, 2006·Alzheimer Disease and Associated Disorders·Robert P Brendza, David M Holtzman
Jun 30, 2006·Journal of Neurochemistry·Huei-Sheng Vincent Chen, Stuart A Lipton
Dec 21, 2006·Biochemistry·Robert W HeplerJoseph G Joyce
Apr 4, 2007·Neurobiology of Aging·Fernanda G De FeliceWilliam L Klein

❮ Previous
Next ❯

Citations

Nov 23, 2012·ACS Chemical Neuroscience·Laramie P JamesonSergei V Dzyuba
Nov 23, 2012·ACS Chemical Neuroscience·Pauline T VelascoWilliam L Klein
Jan 12, 2012·The Journal of Biological Chemistry·Adriano SebollelaSergio T Ferreira
Oct 18, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jason PittWilliam L Klein
Apr 12, 2012·Cold Spring Harbor Perspectives in Biology·Morgan ShengThomas C Südhof
Oct 24, 2013·Molecular Neurodegeneration·Bart P F Rutten, Harry W M Steinbusch
Jun 21, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Elvira ValeraDavid Schubert
Jan 15, 2011·International Journal of Alzheimer's Disease·Jo V Rushworth, Nigel M Hooper
Jun 11, 2011·Biomarkers in Medicine·Paulina D Rakowska, Maxim G Ryadnov
Nov 26, 2010·Immunotherapy·Francesco PanzaVincenzo Solfrizzi
Jan 24, 2014·Molecular Neurobiology·Silvia BologninMario Buffelli
Jan 6, 2012·Neurochemical Research·Petra SánthaJános Kálmán
Dec 20, 2015·Journal of Alzheimer's Disease : JAD·Mrinmay ChakrabartiSwapan K Ray
Oct 25, 2014·ACS Chemical Neuroscience·Adriano SebollelaWilliam L Klein
Dec 3, 2015·ACS Chemical Neuroscience·Natália E C de AlmeidaMichael T Bowers
Feb 18, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Fernanda G De FeliceSergio T Ferreira
Apr 10, 2014·The European Journal of Neuroscience·Dezhi LiaoPeter J Teravskis
Jun 26, 2014·Chembiochem : a European Journal of Chemical Biology·Marie C HeffernThomas J Meade
Apr 16, 2013·Neurobiology of Aging·Christina Unger LithnerCaterina M Hernandez
Jun 16, 2015·Frontiers in Cellular Neuroscience·Sergio T FerreiraFernanda G De Felice
May 23, 2014·Frontiers in Neurology·Yue-Qin ZengXin-Fu Zhou
May 11, 2016·Proceedings of the National Academy of Sciences of the United States of America·Takahiro Watanabe-NakayamaMasahito Yamada
Apr 1, 2017·Expert Opinion on Investigational Drugs·Chris G Parsons, Gerhard Rammes
Oct 11, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Botond PenkeLívia Fülöp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.